Not exact matches
In a study published in Neoplasia, researchers at the Washington University School of Medicine created a map showing which
genes were switched on and off in
different parts of the
tumor, providing a «signature» of these switches throughout the genome.
The genome - wide epigenetic changes clustered in certain chromatin domains and controlled «
gene expression changes that specify
different malignant traits, including the ability to form
tumors,» McDonald said.
The expression of all human
genes was analyzed in these
tumors and correlated with
different clinical parameters.
PTEN prevents
tumor cells from growing uncontrollably, and mutations in the
gene encoding this protein are commonly found in many
different types of cancer.
African - Americans, on the other hand, experienced heightened mutations in BCL7A, a
different tumor suppressor
gene.
They tested these drugs one at a time for lethal interaction with 112
different tumor - suppressor
gene mutations in human cancer cells growing in the lab.
In this mouse model, mutations in Kras and p53
genes resulted in the formation of individual
tumor cell populations that were labeled with
different colors.
Curious about the possibility of circular RNAs contributing to cancer, Pandolfi and his colleagues set out to see if they could detect relevant changes in
tumors known to harbor distinct fusion proteins, which result when
different chromosomes abnormally join together, melding two separate
genes into a new centaur - like
gene.
The resulting «map» of
gene - drug interactions allowed the researchers to accurately predict the responses of multiple human cancer cell lines to
different chemotherapy agents based on the cell lines» genetic profiles and also revealed new genetic factors that appear to determine the response of breast and ovarian
tumor cells to common classes of chemotherapy treatment.
Unfortunately, in some cases, the
tumor uses
different epigenetic mechanisms, independent of estrogen, to repress the HOXC10
gene.
Both Tsigelny and Kurzrock agreed that this finding is an excellent example of the power of collaboration between SDSC and the Moores Cancer Center, and that such modeling needed to be studied across
tumors and with multiple
different genes involved in cancer.
This same feature,
tumor heterogeneity, may reduce the ability to identify critical
gene expression changes when comparing mean
gene expression in adjacent
tumor and normal tissues, as
tumors of the same type may have
different sets of
genes differentially expressed.
Surprisingly, they found that although the patterns of
gene expression — as shown by the RNA sequencing — differed between the hepatocellular carcinomas and the liver cancers with biliary phenotype and depended on the histological type, the overall pattern of mutations in the cells was actually similar between the
tumors — of either type — that had emerged in patients who had had infections with either hepatitis C or B, and were
different in patients without such infections.
The method is based on the knowledge that
different tumors can be driven by
different subsets of cancer
genes.
Put simply, the pattern of microRNA
genes turned on in one kind of
tumor was entirely
different from the pattern in another kind of
tumor, and entirely
different again from that seen in healthy cells.
They're continuing to sequence prostate
tumors to learn how frequently
different mutations occur, as well as studying which of the rearranged
genes are actually driving cancer.
The team also found that these
genes had
different functions in promoting metastasis: One group encouraged growth of
tumor cells in both breast and lungs, whereas the other only helped the new
tumor thrive in the lungs.
Within this cascade Shp2 turns on
different signaling molecules, but turns off the
tumor suppressor
genes p27 und p53.
Many
tumor suppressor and receptor
genes have been reported to be hypermethylated and transcriptionally silenced during the development of
different types of cancers.
A research team led by Kerstin Lindblad - Toh at Uppsala University / SciLifeLab has used genetic analyses of 25
different dog breeds to identify
genes that could have a role in the development of brain
tumors.
Han et al. demonstrated that in Caco2 cells, extracellular NAD + inhibited the binding of NF - kB to DNA by blocking the transcription of
different genes involved in both inflammatory and aging pathways (interlukin - 6, interlukin - 1 beta,
tumor necrosis factor alpha) 27.
The federal government is launching a very
different kind of cancer study that will assign patients drugs based on what
genes drive their
tumors rather than the type.
Dendritic cells reconstituted with human telomerase
gene induce potent cytotoxic T - cell response against
different types of
tumors.
The research also showed that
gene expression patterns of individual
tumors varied considerably, and could exceed the variation observed between
different cancer types.
In these deadly dispersed
tumors, Trotman and his colleagues were surprised to find that a
different cancer
gene, called Myc, had taken over.
Resolve the genomic diversity in a variety of
tumors by targeting hotspots across 50 oncogenes and
tumor suppressor
genes relevant in a range of
different solid
tumors with SNV and indel mutation detection.
Lemmon is collaborating with oncologists at Penn who have sequenced the ALK
gene in nearly 2000 neuroblastoma
tumors and found 50
different mutations.
Krogan believes that mutations in a few key networks of
genes cause diseases like cancer, even though the individual
genes that are mutated in
tumors vary between
different people and
different types of cancer.
Examples include the study of allelic variation in the human genome and the development of computational methods for the discovery of cancer - associated
genes and diagnostic cancer markers using genomic profiles derived from
different tumor types.
Do they all impinge on some final common pathway and does the
tumor specificity reside in the fact that in
different tissues, there are
different redundancies so that a particular
gene may have a redundant helper in some tissues but not in others?
There are several
different treatments being compared, including: surgery followed by vaccine - based immunotherapy, surgery followed by oncolytic virus therapy, surgery followed by IL - 12
gene therapy and biopsy followed by placement of a specialized catheter system that draws
tumor cells out of the brain.